EnteroTrack focuses on innovation in gastrointestinal medicine.
EnteroTrack has raised $2.0M in total funding. The most recent round was Convertible Note. The last funding was announced in September 2026.
EnteroTrack's investors include CancerX Startup Accelerator.
EnteroTrack is headquartered in Centennial, United States.
EnteroTrack focuses on innovation in gastrointestinal medicine.
EnteroTrack is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EnteroTrack — Funding & Investors." VCBacked, September 25, 2026, https://www.vcbacked.co/company/enterotrack. Accessed November 15, 2026.
VCBacked. (2026). EnteroTrack — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/enterotrack
{{cite web |title=EnteroTrack — Funding & Investors |url=https://www.vcbacked.co/company/enterotrack |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at EnteroTrack? Request a listing update